sulperazone

12/01/1996 - "[A randomized controlled clinical trial of sulperazon in the treatment of surgical infection]."
01/01/2003 - "[Sulperazone in the treatment of severe infections in patients with cancer]."
07/01/1995 - "Sulperazone is promising in the treatment of burn infection."
04/01/2009 - "Sulperazone or Amikacin may be used in severe biliary infection. "
01/01/2021 - "Meanwhile, in the severe situation of NEC with intestinal infection, the first therapy strategy is preferred the third-generation cephalosporin, among which sulperazone is used widely and the effect is remarkable. "

09/01/2005 - "Both maxipime and sulperazon are effective and safe for application in children with moderate and severe respiratory infections."

11/17/2004 - "Both ceftriaxone and sulperazon are effective in treating acute suppurative cholangitis when used before and after choledochostomy. "
11/17/2004 - "To compare the efficacy of ceftriaxone and that of cefoperazone plus sulbactam (sulperazon) in controlling infection, in scavenging bacteria from bile, and in their costs when treating acute suppurative cholangitis with choledochostomy. "

07/01/1995 - "Sulperazone is promising in the treatment of burn infection."
07/01/1995 - "[In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds]."
05/01/1995 - "[A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection]."
07/01/1995 - "Sulperazone (SLP), a combination of sulbactam (beta-lactamase inhibitor) with cefoperazone (CFP), was studied in vitro for its sensitivity to multi-resistant strains of bacteria isolated from burn wounds. "
05/01/1995 - "The experience with the use of sulperazone (a combination of cefoperazone, a 3rd generation cephalosporin, and sulbactam, a beta-lactamase inhibitor, Pfizer, USA) in the treatment of 25 patients with burns and deep burns (1 to 85 and 1 to 70 per cent of the body surface affection respectively) is described. "

07/01/2023 - "We describe a 62-year-old man with new-onset acute reactive thrombocytopenia who experienced a precipitous fall in the platelet count from 168×109/L to 1×109/L within 29 hours after exposure to sulperazon. "
07/01/2023 - "The purpose of this study is to report a patient who developed acute reactive thrombocytopenia while undergoing treatment with sulperazon for systemic lupus erythematosus (SLE). "
07/01/2023 - "Sulperazon-induced acute reactive thrombocytopenia during treatment of systemic lupus erythematosus: a case report."